Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating acute bronchiolitis associated with RSV.

Robert William Prasaad Steiner1

  • 1Department of Family and Community Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA. r.steiner@louisville.edu

American Family Physician
|February 10, 2004
PubMed
Summary

Supportive care is key for infant bronchiolitis from respiratory syncytial virus (RSV). While some treatments show limited effectiveness, infection control measures can reduce hospital-acquired RSV infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient identification of adults with depression and dementia.

American family physicianยท2004
See all related articles

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Bronchiolosis is a common viral respiratory infection in infants, primarily caused by respiratory syncytial virus (RSV).
  • Current management focuses on supportive care, but the efficacy of various pharmacological interventions remains under investigation.
  • Identifying high-risk infants is crucial for determining appropriate levels of care and potential hospitalization.

Purpose of the Study:

  • To review current treatment strategies for infants with respiratory syncytial virus (RSV) bronchiolitis.
  • To evaluate the effectiveness of different therapeutic interventions, including bronchodilators, corticosteroids, and prophylactic agents.
  • To highlight the importance of infection control in preventing nosocomial RSV transmission.

Main Methods:

Related Experiment Videos

  • Literature review of studies on RSV bronchiolitis treatment.
  • Analysis of clinical trial data and meta-analyses regarding treatment efficacy.
  • Examination of guidelines and recommendations from health organizations.

Main Results:

  • Supportive care, including oxygen, suctioning, and hydration, forms the cornerstone of treatment.
  • Inhaled bronchodilators and nebulized epinephrine have not demonstrated consistent efficacy, though some sources suggest possible effectiveness.
  • Corticosteroid use is controversial due to inconsistent meta-analysis results.
  • Prophylaxis with palivizumab can reduce hospitalizations in high-risk infants but faces challenges in administration and cost.
  • Infection-control measures are effective in reducing RSV transmission in healthcare settings.

Conclusions:

  • Supportive care remains the primary treatment for RSV bronchiolitis.
  • The efficacy of bronchodilators, epinephrine, and corticosteroids is not definitively established and warrants further research.
  • Prophylactic options exist for high-risk infants but are limited by practical and economic factors.
  • Implementing infection-control strategies is vital for preventing the spread of RSV in clinical environments.